Moreover, the role of endogenous glucagon-like peptide 1 (GLP-1) in the body is reviewed, including neuronally synthesized GLP-1, with a focus on how recent research developments may point towards therapeutic utility of GLP-1RAs in neuro-ophthalmology
Effects in PCOS GLP-1 RAs have been extensively studied in women with PCOS due to overlapping metabolic abnormalities
Realistic timeline from assessment to first dose: 5-10 business days
[2] Consequently, less than 25% of secreted GLP-1 is estimated to leave the gut intact
Pinto agrees that people should feel empowered to talk to their healthcare providers about any symptoms they are experiencing
In fact, the goal of GLP-1 use is to focus on physical health, mental health and well-being, rather than body weight alone (Mozafarriun et al 2025)